Skip to main content
20th International Myeloma Workshop Main banner
Back

    Faith E. Davies, MD (she/her/hers)

    Professor of Medicine, Director of the Center for Blood Cancers Director of the Clinical Myeloma Pro
    Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA, United States

    Faith E. Davies, MBBCh, MRCP, MD, FRCPath
    Director, Clinical Myeloma Program, Perlmutter Cancer Center
    Professor Of Medicine, NYU Grossman School of Medicine
    NYU Langone Health

    Faith E. Davies earned her medical degree from the University of Wales College of Medicine and completed her general medical training and hematology specialty training in the UK. Prior to joining the faculty of NYU Langone, New York, Dr. Davies held positions with the University of Arkansas for Medical Sciences, Arkansas, USA and the Institute of Cancer Research / Royal Marsden Hospital, in London, UK.

    Her research focus for over two decades has been on the biology and treatment of multiple myeloma, in particular the examination of potential new drugs and new genetic technologies. She is recognized internationally for her work looking at prognostic and predictive biomarkers (e.g. genetic abnormalities, imaging and minimal residual disease) within the context of clinical trials. Dr. Davies laboratory work is aimed at identifying biologically based therapeutic targets in myeloma that are amenable to small molecule interventions and translating those laboratory findings into the clinical arena with a focus on individualized treatment.

    Dr. Davies is a member of the American Society of Hematology, the American Association for Cancer Research, the Royal College of Physicians (UK), and the Royal College of Pathologists (UK). She is widely published in leading peer-reviewed journals, including the New England Journal of Medicine, Lancet Oncology, Blood, Journal of Clinical Oncology, and Leukemia.

    Presentation(s):